How does the complexity of cancer biology hinder progress?
The sheer complexity of cancer biology is one of the most significant hurdles in combating the disease. Cancer involves multiple genetic mutations, interactions with the surrounding microenvironment, and the ability to evade the immune system. This complexity makes it difficult to identify universal biomarkers or therapeutic targets. Moreover, the adaptability of cancer cells means that they can quickly develop resistance to treatments, necessitating a continuous search for new strategies. Understanding the intricate mechanisms of cancer progression and interaction with the host remains a formidable challenge.
